Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.
about
Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccinePerformance of rotavirus vaccines in developed and developing countriesEnvironmental enteropathy: critical implications of a poorly understood condition.The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysisAntigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired choleraCirculation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993The role of research in viral disease eradication and elimination programs: lessons for malaria eradicationVaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirusRecombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.Systems vaccinology: probing humanity's diverse immune systems with vaccines.Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forwardEradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issueEnvironmental enteric dysfunction: an overviewImmunology of Gut Mucosal VaccinesSero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.Pediatric small intestine bacterial overgrowth in low-income countries.Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort studyEstimating the extent of vaccine-derived poliovirus infection.Do antenatal parasite infections devalue childhood vaccination?Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.Vaccines against human diarrheal pathogens: current status and perspectivesCommunity engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.The effect of rotavirus vaccine on diarrhoea mortalityShould the human microbiome be considered when developing vaccines?Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria.Genomic characterization of human and environmental polioviruses isolated in Albania.The role of older children and adults in wild poliovirus transmissionHuman infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneFrom emergence to eradication: the epidemiology of poliomyelitis deconstructedChronic Schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice.Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.Effect of antenatal parasitic infections on anti-vaccine IgG levels in children: a prospective birth cohort study in Kenya.Partition and poliomyelitis: an investigation of the polio disparity affecting Muslims during India's eradication program.An evolving perspective about the origins of childhood undernutrition and nutritional interventions that includes the gut microbiome.Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.A Single Dose of Oral BCG Moreau Fails to Boost Systemic IFN-γ Responses to Tuberculin in Children in the Rural Tropics: Evidence for a Barrier to Mucosal Immunization.The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
P2860
Q21245322-CD1CF7BA-F730-478C-AE60-E53A40DD27DDQ24600612-EA726A3E-2D51-4ECE-B2B0-9E1543B9B058Q24606211-EE7EA153-087C-4157-ACB7-7B71EE6A347CQ24617876-C2741A39-34B8-473D-A0C9-E733AD264AA7Q24620207-20B6A275-5C1A-4643-B393-E14125D6384FQ24682487-C115F699-9F57-4590-B7C4-4A41C1A77BFAQ26700366-EA2963A0-7D29-4573-A105-9E8011CC17C3Q26995690-E584BB22-A682-4C04-830B-BAC4329E6FF2Q27469474-A8CF148A-A086-430B-8221-0E955D6691B7Q27690799-839A5B2B-72D5-4DE1-B9CA-88DCFDF592F1Q27694492-633C994B-3E7A-4F15-AF82-ED63E69B5B76Q28077094-B3D888CF-D1AE-4B15-8323-47C93F3F98C2Q28261015-B8870794-CA88-4D54-9463-A8DD583EE2C3Q28972559-15485455-13BA-4F74-8EE9-DAD14B733094Q30209499-A6241D38-A89E-4103-AA08-1BDD3DBCA626Q30301148-786A6BD3-C058-4DA8-AAB3-20D302321F82Q30431350-62C81F55-A3A9-442A-BA87-376B99304B10Q33380220-417DFB0F-FA8A-4B11-9589-510906FA17C4Q33455457-5152DDC6-0D90-44A2-BB01-B1143BE07BADQ33578033-9184A077-4138-4FB9-9947-364BBB192782Q33578045-39F8D3E9-1A6F-4A3A-A575-E5A6DABF10F3Q33711034-0E2F96B0-7E24-4844-842C-316DFEF4527CQ33754470-9FA49529-2FA5-4B24-9FDE-47CC8A86C9ABQ33761388-DFAE21D4-9FFF-4A8A-98A2-F8CF6FEF095BQ33791473-5E630165-D075-455B-AD7E-7270D0F3391BQ33869472-144742E4-77E7-4B0C-B55F-047224CFC00FQ33971682-CC20BBCE-07F7-4811-BFEF-57FE8F80E1B4Q34006359-5F1CDC5A-BA55-4E9D-8575-459D4D53C3E3Q34244892-21E4F8E6-D6BD-49CE-8C6C-26ACDBB04E8AQ34328895-C2617B86-6CD1-4225-AF4E-6F4924D46441Q34349482-B4E1205B-0BBA-4648-84F8-7824906E1624Q34525309-191BCF83-D4D0-453A-8685-361F144FAF55Q34743352-DC0E4508-ACFE-4D36-8283-273929CE6E7EQ34973448-09B7E08B-4CF6-4477-AE33-89DEFCBB2161Q35151687-21178543-D4AC-4B53-949F-1D2C6ED8C6BBQ35223836-D1DE2F9C-62D6-4F60-979F-5F5D3416A28DQ35273267-C8E07E51-CDA1-47F2-9806-7FA96429980DQ35662053-EEDFB06F-A6C0-47B7-87C7-09A5F7D05FEDQ35687523-88B8D505-B706-4F4B-B7C5-19AFB954E3F7Q35779856-3B49DD01-BF0B-4A0A-B60B-0881BA6E103C
P2860
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Factors affecting the immunoge ...... developing countries: review.
@ast
Factors affecting the immunoge ...... developing countries: review.
@en
type
label
Factors affecting the immunoge ...... developing countries: review.
@ast
Factors affecting the immunoge ...... developing countries: review.
@en
prefLabel
Factors affecting the immunoge ...... developing countries: review.
@ast
Factors affecting the immunoge ...... developing countries: review.
@en
P2093
P1476
Factors affecting the immunoge ...... developing countries: review.
@en
P2093
P304
P577
1991-09-01T00:00:00Z